The Optimal Adjuvant Strategy of Aidi Injection With Gemcitabine and Cisplatin in Advanced Non–small Cell Lung Cancer: A Meta-analysis of 70 Randomized Controlled Trials

Introduction: Aidi injection (Aidi) is composed of cantharidin, astragaloside, ginsenoside, and elentheroside E. As an important adjuvant therapy, Aidi in combination with gemcitabine and cisplatin (GP) is often used in the treatment of non-small cell lung cancer (NSCLC). Objectives: We performed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cheng-Qiong, Zheng, Xiao-Tian, Chen, Xiao-Fan, Jiang, Hong, Huang, Jun, Jiang, Yuan, Hu, Shan-Shan, Huang, Xiao-Rong, Liu, Shi-Yu, Gong, Qi-Hai, Feng, Ji-Hong, Xiao, Xue, Li, Xiao-Fei, Xiao, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194277/
https://www.ncbi.nlm.nih.gov/pubmed/34122057
http://dx.doi.org/10.3389/fphar.2021.582447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194277/
https://www.ncbi.nlm.nih.gov/pubmed/34122057
http://dx.doi.org/10.3389/fphar.2021.582447

Ejemplares similares